12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

Biogen Idec, MAKScientific deal

MAKScientific granted Biogen Idec an option to license exclusive, worldwide rights to develop and commercialize discovery-stage products for multiple sclerosis (MS)...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >